NervGen Pharma Corp. (NGEN)

NervGen Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	324	446	153	122	70	97
Market Cap Growth	120.30%	190.81%	26.05%	74.14%	-27.73%	58.13%
Enterprise Value	309	438	138	111	50	90
Last Close Price	3.88	5.60	2.18	2.04	1.19	2.13
PB Ratio	121.87	175.77	85.59	-79.93	7.02	7.27
P/TBV Ratio	145.41	199.21	104.44	-	7.25	7.48
Debt / Equity Ratio	0.00	0.00	0.04	-0.10	0.02	-
Net Debt / Equity Ratio	-6.34	-6.34	-6.66	5.71	-1.65	-1.01
Net Debt / EBITDA Ratio	0.88	0.88	0.68	0.65	0.97	1.33
Net Debt / FCF Ratio	1.13	1.13	1.02	1.01	1.25	2.05
Quick Ratio	1.12	1.12	1.05	0.79	2.20	15.76
Current Ratio	1.16	1.16	1.13	0.83	2.27	16.16
Return on Equity (ROE)	-1457.57%	-1457.57%	-8546.24%	-390.89%	-136.87%	-111.94%
Return on Assets (ROA)	-73.42%	-73.42%	-96.17%	-59.88%	-68.90%	-65.17%
Return on Capital Employed (ROCE)	-721.30%	-721.30%	-973.90%	933.90%	-168.60%	-76.20%
Earnings Yield	-9.89%	-7.22%	-11.00%	-13.94%	-21.93%	-10.41%
FCF Yield	-4.39%	-3.19%	-7.64%	-7.04%	-18.84%	-6.77%
Buyback Yield / Dilution	-7.44%	-7.44%	-13.55%	-12.61%	-34.00%	-22.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.